- Q1 2024 Lucid Diagnostics Inc Earnings Call TranscriptMay 13, 2024$0.95 (+0.59%)Earnings
- Q4 2023 Lucid Diagnostics Inc Earnings Call TranscriptMar 26, 2024$0.99 (-6.60%)Earnings
- Q3 2023 Lucid Diagnostics Inc Earnings Call TranscriptNov 14, 2023$1.3 (+12.07%)Earnings
- Q2 2023 Lucid Diagnostics Inc Earnings Call TranscriptAug 15, 2023$1.49 (+0.34%)Earnings
- Lucid Diagnostics Inc Annual Shareholders Meeting TranscriptJun 21, 2023
- Q4 2022 Lucid Diagnostics Inc Earnings Call TranscriptMar 14, 2023$1.72 (+6.83%)Earnings
- PAVmed Inc, Lucid Diagnostics Inc and Veris Health Inc Strategic Business Update Call TranscriptJan 17, 2023
- Q3 2022 Lucid Diagnostics Inc Earnings Call TranscriptNov 14, 2022$2.27 (+1.79%)Earnings
- Q2 2022 Lucid Diagnostics Inc Earnings Call TranscriptAug 15, 2022$3.35 (-1.18%)Earnings
- Lucid Diagnostics Inc Annual Shareholders Meeting TranscriptJun 21, 2022
- Q1 2022 Lucid Diagnostics Inc Earnings Call TranscriptMay 11, 2022$1.86 (-7.46%)Earnings
- Lucid Diagnostics Inc at Needham Healthcare Conference (Virtual) TranscriptApr 12, 2022
Q1 2024 Lucid Diagnostics Inc Earnings Call Transcript
Good morning and welcome to the Lucid Diagnostics first-quarter 2024 Business Update Conference Call. (Operator instructions) Please note that this event is being recorded.
And I would now like to turn the conference over to Matt Riley, Lucy Diagnostics' Director of Investor Relations.
_____ Matt Riley
Thank you, operator, and good morning, everyone. Thank you for participating today's business update call. Joining me today on the call are Dr. Lishan Aklog, Chairman and Chief Executive Officer of Lucid Diagnostics, along with Dennis McGrath, Chief Financial Officer for Lucid Diagnostics.
The press release announcing our business update and financial results is available on Lucid's website. Please take a moment to read the disclaimers about forward-looking statements in the press release, business update, press release and the conference call all include forward-looking statements and these forward-looking statements are subject to known and unknown risks and
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)